Peter van Rossum, Radiation Oncologist at Amsterdam UMC, shared a post on LinkedIn about an article he and his colleagues authored:
“Our new article as part of the exciting “Controversies in Thoracic Oncology” section of JTO is now online!
We argue that even in the era of CNS-penetrant TKIs, upfront (or very early) brain radiotherapy still has an important role for patients with oncogene-driven NSCLC and brain metastases.
Read it here.
Title: Given TKIs With High CNS Penetrance, Systemic Therapy Should Be Administered Before Radiation Therapy for CNS Metastases
Authors: Laura Alder, Sandip P. Patel, Thomas E. Stinchcombe
Worthy opponents (Laura Alder, MD and team) discuss the viewpoint of deferring such radiotherapy.
Many thanks to co-authors Sayed Hashemi, Joost Verhoeff, Patricia de Haan, Famke Schneiders and Suresh Senan for the great collaboration!”
Title: Even With CNS-Penetrant TKIs, Radiation Therapy Should Be Used Before Systemic Therapy For CNS Metastases
Authors: Peter S.N. van Rossum, Sayed M.S. Hashemi, Joost J.C. Verhoeff, Patricia F. de Haan, Famke L. Schneiders, Suresh Senan
More posts featuring Radiation Therapy on OncoDaily.